Evaluation of the Radiation Dose of an Embryo/Fetus during Lymphoscintigraphy (Sentinel Lymph Node Mapping) in Pregnant Patients with Breast Cancer

Purpose: To develop a method for evaluation of the radiation dose of an embryo/fetus during lymphoscintigraphy (sentinel lymph node mapping) in pregnant patients with breast cancer.
Material and methods: Two pregnant women (aged 43 and 30) with breast cancer stage IIA (T₂N₀M₀), during the second trimester of pregnancy. We used a lymphotropic colloidal radiopharmaceutical labeled with ^99mTc. To evaluate the radiation dose of an embryo, each patient had 6 individual dosimeters, which were placed around the abdomen using an elastic bandage at equal distances around the abdomen. Additionally, we placed the 7th dosimeter, it was placed near the injection site (under the mammary gland). After installing individual dosimeters, radiocolloid was injected into the affected mammary gland at four points (periareolar). The administered activity of radiopharmaceutical was 32.5 MBq, and 51.5 MBq. Lymphoscintigraphy was performed 1 hour after injection. First patient underwent sector resection of the left breast with SLN biopsy. The second patient underwent right mastectomy with SLN biopsy and breast reconstruction surgery using a tissue expander.
Results: Based on the results of the study, the dose rate was calculated, on the basis of which the fetal radiation doses were calculated in both patients. Comparison of the mathematical data of both patients shows that, the calculated and experimental values of radiation exposure to the fetus during the radionuclide study of sentinel lymph nodes practically coincide. The obtained data shows that during pregnancy (280 days) the embryo/fetus will accumulate a natural radiation background dose of 1960 μSv, which is 2 times higher than the dose from the radionuclide study of sentinel lymph nodes. Thus these results verify the safety of SLN biopsy technology in pregnancy.
Conclusion: 1. Radionuclide diagnostic studies of pregnant women determine radiation doses to the embryo/fetus that do not cause any radiation-induced effects in the prenatal period, and the probability of the occurrence of stochastic radiation-induced effects is several times lower than the incidence of endogenous cancers. 2. Radionuclide examination of sentinel lymph nodes appears to be safe for the fetus when conducted in pregnant women diagnosed with breast cancer. 3. In Russian Federation this method is used for the first time in pregnant women with diagnosed breast cancer. This technology has not been previously described in Russian literature.

1. Рыжков АД, Билик МЕ, Крылов АС и др. Сцинтиграфия и ОФЭКТ/КТ сторожевых лимфатических узлов в планировании оперативного вмешательства при раке молочной железы. Медицинская радиология и радиационная безопасность. 2018;63(4):50–57 [Ryzhkov AD, Bilik ME, Krylov AS, et al. Scintigraphy and SPECT/CT of sentinel lymph nodes for planning of operative intervention in breast cancer. Medical Radiology and Radiation Safety. 2018;63(4):50-7 (In Russian)]. DOI: 10.12737/article_5b83bc-2b3c3ef1.05312079

2. СанПиН 2.6.1.2523 — 09. Нормы радиационной безопасности НРБ-99/2009. Санитарные правила и нормативы. 2009. [SanPiN 2.6.1.2523-09. Radiation Safety Standards NRB-99/2009. Sanitary Rules and Regulations. 2009 (In Russian)].

3. Публикация 103 МКРЗ. Рекомендации 2007 года Международной комиссии по радиационной защите. Пер. с англ. М.: Изд. ООО ПКФ «Алана». 2009. 344 с. [ICRP Publication 103. The 2007 Recommendations of the International Commission on Radiological Protection. Ann. ICRP 2007;37(2-4) (In Russian)].

4. ICRP Publication 84. Pregnancy and Medical Radiation. Ann ICRP. 2000; 30(1).

5. Машкович ВП, Кудрявцева АВ. Защита от ионизирующих излучений. Справочник. 4-е изд. М.: Энергоатомиздат. 1995. [Mashkovich VP, Kudryavtseva AV. Protection against Ionizing Radiation. Directory. 4th ed. Moscow. 1995 (In Russian)].

6. Ильин ЛА, Коренков ИП, Наркевич БЯ. Радиационная гигиена. 5-е изд., перераб. и доп. М. : ГЭОТАР-Медиа, 2017.[Ilyin LA, Korenkov IP, Narkevich BYa. Radiation Hygiene. 5th ed., Moscow, 2017 (In Russian)].

7. Mátrai Z, Bánhidy F, Téglás M, et al. Sentinel lymph node biopsy in pregnancy-associated breast cancer. Orv Hetil. 2013;154(50):1991-7. DOI: 10.1556/oh.2013.29771

8. Gropper A, Calvillo K, Dominici L, et al. Sentinel Lymph Node Biopsy in Pregnant Women with Breast Cancer. Ann Surg Oncol. 2014;21(8):2506-11. DOI: 10.1245/s10434-014-3718-2

9. Han S, Amant F, Cardonick E, et al. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy. Breast Cancer Res Treat. 2017;168(2):551-7. DOI: 10.1007/s10549-017-4611-z

10. Balaya V, Bonsang-Kitzis H, Ngo C, et al. What about sentinel lymph node biopsy for early breast cancer during pregnancy? J Gynecol Obstet Hum Reprod. 2018;47(5):205-7. DOI: 10.1016/j.jogoh.2018.03.003

11. Gentilini O, Cremonesi M, Toesca A, et al. Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging. 2009;37(1):78-83. DOI: 10.1007/s00259-009-1217-7